List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 21 studies with search of:   "Delavirdine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Delavirdine mesylate;   Drug: Lamivudine;   Drug: Zidovudine
2 Completed A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies
Condition: HIV Infections
Intervention: Drug: Delavirdine mesylate
3 Completed A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Delavirdine mesylate;   Drug: Zidovudine
4 Terminated A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Lamivudine/Zidovudine;   Drug: Nelfinavir mesylate;   Drug: Saquinavir;   Drug: Delavirdine mesylate
5 Completed Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Delavirdine mesylate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine
6 Completed A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy
Condition: HIV Infections
Interventions: Drug: Delavirdine mesylate;   Drug: Zidovudine;   Drug: Didanosine
7 Completed A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3
Condition: HIV Infections
Interventions: Drug: Delavirdine mesylate;   Drug: Didanosine
8 Completed A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3
Condition: HIV Infections
Interventions: Drug: Delavirdine mesylate;   Drug: Lamivudine;   Drug: Zidovudine
9 Terminated The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
Condition: HIV Infections
Interventions: Drug: Emivirine;   Drug: Hydroxyurea;   Drug: Delavirdine mesylate;   Drug: Stavudine;   Drug: Didanosine
10 Completed A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Delavirdine mesylate;   Drug: Lamivudine;   Drug: Zidovudine
11 Completed Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Nelfinavir mesylate;   Drug: Delavirdine mesylate;   Drug: Stavudine;   Drug: Didanosine
12 Completed Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)
Condition: HIV Infections
Interventions: Drug: Delavirdine mesylate;   Drug: Zidovudine;   Drug: Didanosine
13 Completed A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Nelfinavir mesylate;   Drug: Levocarnitine;   Drug: Adefovir dipivoxil;   Drug: Saquinavir;   Drug: Delavirdine mesylate
14 Active, not recruiting Safety And Efficacy Of RESCRIPTOR In Patients For HIV Patients
Condition: HIV Infections
Intervention: Drug: Rescriptor
15 Completed The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine
Condition: HIV Infections
Interventions: Drug: Delavirdine mesylate;   Drug: Zidovudine
16 Terminated Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Ritonavir;   Drug: Delavirdine mesylate
17 Completed A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Nelfinavir mesylate;   Drug: Saquinavir;   Drug: Delavirdine mesylate
18 Completed A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Nelfinavir mesylate;   Drug: Saquinavir;   Drug: Delavirdine mesylate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine
19 Completed Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Saquinavir;   Drug: Delavirdine mesylate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine
20 Recruiting Safety and Effectiveness of Addition of Maraviroc to ART Regimens in HIV-Infected Adults With Suboptimal CD4 T-Cell Count Recovery Despite Sustained Virologic Suppression
Condition: HIV Infections
Intervention: Drug: Maraviroc

Previous Page Studies Shown (1-20) Next (21-21)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services